MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Myriad Genetics Operating Cycle 2011-2025 | MYGN
Annual Operating Cycle Myriad Genetics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.1 | 84.8 | 83.9 | 47.8 | 136 | 49.8 | 119 | 143 | 135 | 106 | 120 | 81.1 | 112 | 90.4 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 143 | 47.8 | 99.7 |
Quarterly Operating Cycle Myriad Genetics
| 2025-Q3 | 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | 97.1 | - | 89.7 | 86.8 | 85.3 | - | 91.7 | 92.4 | 87.9 | - | 47.5 | 40.2 | 82.8 | - | 51.4 | 45.5 | 48.4 | 52.8 | 56.2 | 87.6 | 65.3 | 55 | 61.5 | 62.6 | 61.4 | 49.6 | 49.3 | 41.9 | 142 | 148 | 151 | 75.2 | 162 | 176 | 171 | 136 | 135 | 124 | 130 | 108 | 108 | 97.3 | 110 | 103 | 78 | 48.1 | 62 | 66.5 | 75.8 | 104 | 115 | 105 | 107 | 104 | 112 | 95.9 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 176 | 40.2 | 91.3 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Burning Rock Biotech Limited
BNR
|
275 | $ 16.36 | -4.05 % | $ 176 M |  China |
 |
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
329 | $ 1.63 | -2.11 % | $ 2.07 M | USA |
 |
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | USA |
 |
IQVIA Holdings
IQV
|
78 | $ 221.54 | -1.96 % | $ 40.2 B | USA |
 |
Castle Biosciences
CSTL
|
97.9 | $ 38.85 | 2.32 % | $ 1.08 B | USA |
 |
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | China |
 |
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | China |
 |
Danaher Corporation
DHR
|
150 | $ 227.08 | -2.28 % | $ 166 B | USA |
 |
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | USA |
 |
DarioHealth Corp.
DRIO
|
251 | $ 11.92 | -6.58 % | $ 338 M |  Israel |
 |
DexCom
DXCM
|
204 | $ 66.91 | -2.94 % | $ 25.8 B | USA |
 |
CareDx, Inc
CDNA
|
76.4 | $ 20.44 | 3.23 % | $ 1.1 B | USA |
 |
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | USA |
 |
Anixa Biosciences
ANIX
|
385 | $ 3.59 | -25.21 % | $ 115 K | USA |
 |
Exact Sciences Corporation
EXAS
|
269 | $ 101.58 | 0.21 % | $ 18.8 B | USA |
 |
Co-Diagnostics
CODX
|
405 | $ 0.34 | -2.96 % | $ 9.98 M | USA |
 |
Fulgent Genetics
FLGT
|
77.4 | $ 27.13 | 0.26 % | $ 820 M | USA |
 |
Guardant Health
GH
|
49.1 | $ 102.09 | 0.7 % | $ 12.5 B | USA |
 |
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
89 | $ 26.6 | -1.52 % | $ 20 B |  Niderland |
 |
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
198 | $ 134.29 | -1.58 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
67.7 | $ 192.57 | -0.96 % | $ 9.89 B | USA |
 |
Quidel Corporation
QDEL
|
68.4 | $ 28.79 | -2.93 % | $ 1.21 B | USA |
 |
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 182.21 | 0.35 % | $ 20.2 B | USA |
|
Biodesix
BDSX
|
41.7 | $ 7.94 | -1.0 % | $ 1.03 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
72.9 | $ 263.51 | -0.46 % | $ 22.1 B | USA |
 |
ICON Public Limited Company
ICLR
|
68.5 | $ 186.28 | -1.92 % | $ 15.4 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
135 | $ 701.07 | -0.91 % | $ 57.8 B | USA |
 |
Lantheus Holdings
LNTH
|
116 | $ 66.11 | 4.76 % | $ 4.57 B | USA |
 |
Agilent Technologies
A
|
161 | $ 139.44 | -2.4 % | $ 42.4 B | USA |
 |
Biomerica
BMRA
|
204 | $ 2.55 | -1.07 % | $ 5.86 M | USA |
 |
Bioventus
BVS
|
267 | $ 7.59 | 2.29 % | $ 475 M | USA |
 |
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
63.7 | $ 1 395.23 | -1.85 % | $ 29.6 B | Schweiz |
 |
ENDRA Life Sciences
NDRA
|
412 | $ 5.47 | -7.6 % | $ 2.94 M | USA |